Testing a new prostate biopsy needle against the usual one
Part of Kidney & urinary clinical trials.
This study compares a new prostate biopsy system/needle with the standard biopsy needle during your scheduled prostate biopsy. It looks at how well the procedure collects tissue for diagnosis and how the tissue samples compare.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult man who is scheduled to have a prostate biopsy
- You are willing and able to sign informed consent
- You can complete a brief verbal check-in about how you’re doing about 5 days after the procedure
- You must be willing to do the 5-day post-procedure assessment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, specially designed biopsy needle system against the standard needle system used for prostate biopsies. The researchers will compare how well each system collects tissue samples from men who have suspicious MRI findings, to see if the new needle might give better results.
This trial compares a new biopsy needle called SUREcore to the standard needle used during prostate biopsies. It aims to see if the SUREcore needle works better or causes less discomfort.
This study compares two different needle sizes used during a prostate biopsy to see which one finds cancer more accurately and causes fewer side effects. It is for people who have not been diagnosed with prostate cancer before and have a suspicious MRI finding.
This study evaluates a new test (PROSTia) that may help doctors better decide if a prostate biopsy is needed when prostate cancer is suspected. It aims to improve diagnosis by using a urine or blood sample before the biopsy.
This study compares two ways of taking prostate biopsies in men with suspected prostate cancer, to see which method finds cancer more accurately. Participation may help doctors choose the best biopsy approach for future patients.
This trial compares a new micro-ultrasound technique to standard ultrasound during prostate biopsy, using MRI results as a guide. It aims to see if the newer method finds cancer more accurately.
Hear when a new Prostate Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.